TRANSTHYRETIN AMYLOID CARDIOMYOPATHY
Clinical trials for TRANSTHYRETIN AMYLOID CARDIOMYOPATHY explained in plain language.
Never miss a new study
Get alerted when new TRANSTHYRETIN AMYLOID CARDIOMYOPATHY trials appear
Sign up with your email to follow new studies for TRANSTHYRETIN AMYLOID CARDIOMYOPATHY, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Heart disease patients switch drugs in hope for better control
Disease control Not yet recruitingThis study is for adults with a heart disease where a protein forms harmful clumps, making it hard for the heart to pump. Researchers want to see if switching patients from their current drug (tafamidis) to a newer one (acoramidis) increases the level of the good protein in their…
Matched conditions: TRANSTHYRETIN AMYLOID CARDIOMYOPATHY
Phase: PHASE4 • Sponsor: Bayer • Aim: Disease control
Last updated Apr 01, 2026 14:42 UTC
-
Experimental drug aims to clean out clogged hearts
Disease control Not yet recruitingThis early study is testing a new drug called coramitug in people with ATTR-CM, a serious heart condition caused by abnormal protein clumps. Researchers want to see if coramitug can help remove these harmful protein deposits from the heart and prevent new ones from forming. They'…
Matched conditions: TRANSTHYRETIN AMYLOID CARDIOMYOPATHY
Phase: PHASE1 • Sponsor: Novo Nordisk A/S • Aim: Disease control
Last updated Apr 01, 2026 14:41 UTC
-
Researchers probe hidden link between two serious heart conditions
Knowledge-focused Not yet recruitingThis study aims to understand how often a second heart condition called cardiac amyloidosis occurs in patients with aortic stenosis (a narrowed heart valve). Researchers will observe 143 patients aged 65-85 who are scheduled for a valve replacement procedure. They will compare th…
Matched conditions: TRANSTHYRETIN AMYLOID CARDIOMYOPATHY
Sponsor: Shanghai Zhongshan Hospital • Aim: Knowledge-focused
Last updated Mar 27, 2026 12:41 UTC